APA   Click to copy
Heger, J.-M., Mattlener, J., Kaul, H., Ferdinandus, J., Schneider, J., Schleifenbaum, J. K., … Borchmann, S. (2026). MRD-2 in the GHSG HD21 trial assessed by a validated circulating tumor DNA sequencing assay. Blood. https://doi.org/10.1182/blood.2025031089

Chicago/Turabian   Click to copy
Heger, Jan-Michel, Julia Mattlener, Helen Kaul, Justin Ferdinandus, Jessica Schneider, Julia K Schleifenbaum, Gundolf Schneider, et al. “MRD-2 in the GHSG HD21 Trial Assessed by a Validated Circulating Tumor DNA Sequencing Assay.” Blood (2026).

MLA   Click to copy
Heger, Jan-Michel, et al. “MRD-2 in the GHSG HD21 Trial Assessed by a Validated Circulating Tumor DNA Sequencing Assay.” Blood, 2026, doi:10.1182/blood.2025031089.

@article{jan-michel2026a,
  title = {MRD-2 in the GHSG HD21 trial assessed by a validated circulating tumor DNA sequencing assay},
  year = {2026},
  journal = {Blood},
  doi = {10.1182/blood.2025031089},
  author = {Heger, Jan-Michel and Mattlener, Julia and Kaul, Helen and Ferdinandus, Justin and Schneider, Jessica and Schleifenbaum, Julia K and Schneider, Gundolf and Schaub, Valdete and Hänel, Mathias and Hellmuth, Johannes C and Dierlamm, Judith and Martin, Sonja and Mathas, Stephan and Meissner, Julia and Pegtel, D Michiel and Zijlstra, Josée M and Ossowski, Anna and Becker, Kerstin and Hallek, Michael and von Tresckow, Bastian and Borchmann, Peter and Borchmann, Sven}
}